These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 7779413

  • 21. Comparative DNA damage and repair induced by misonidazole, CB 1954 and RSU 1069.
    Dale LD, Widdick DA, Edwards DI, Biol GI.
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):995-9. PubMed ID: 2649469
    [Abstract] [Full Text] [Related]

  • 22. Dual action of tirapazamine in the induction of DNA strand breaks.
    Jones GD, Weinfeld M.
    Cancer Res; 1996 Apr 01; 56(7):1584-90. PubMed ID: 8603406
    [Abstract] [Full Text] [Related]

  • 23. DNA damage induced in T50/80 tumour cells following exposure to the bioreductive drug Tirapazamine in combination with a single dose of radiation (12Gy).
    Friery OP, Hejmadi MV, McKeown SR.
    Biochem Soc Trans; 1997 Feb 01; 25(1):135S. PubMed ID: 9057033
    [No Abstract] [Full Text] [Related]

  • 24. Phosphorylated histone H2AX in spheroids, tumors, and tissues of mice exposed to etoposide and 3-amino-1,2,4-benzotriazine-1,3-dioxide.
    Olive PL, Banáth JP, Sinnott LT.
    Cancer Res; 2004 Aug 01; 64(15):5363-9. PubMed ID: 15289343
    [Abstract] [Full Text] [Related]

  • 25. Effect of oxygenation, pH and hyperthermia on RSU-1069 in vitro and in vivo with radiation in the FSaIIC murine fibrosarcoma.
    Teicher BA, Herman TS, Holden SA, Rudolph MB.
    Cancer Lett; 1991 Aug 01; 59(2):109-17. PubMed ID: 1884367
    [Abstract] [Full Text] [Related]

  • 26. Pre- and post-irradiation radiosensitization by SR 4233.
    Zeman EM, Brown JM.
    Int J Radiat Oncol Biol Phys; 1989 Apr 01; 16(4):967-71. PubMed ID: 2703404
    [Abstract] [Full Text] [Related]

  • 27. Genotoxic effects of 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233) and nitrogen mustard-N-oxide (nitromin) in Walker carcinoma cells under aerobic and hypoxic conditions.
    Cahill A, Jenkins TC, Pickering P, White IN.
    Chem Biol Interact; 1995 Mar 30; 95(1-2):97-107. PubMed ID: 7697757
    [Abstract] [Full Text] [Related]

  • 28. Comparison between the comet assay and the oxygen microelectrode for measurement of tumor hypoxia.
    Aquino-Parsons C, Luo C, Vikse CM, Olive PL.
    Radiother Oncol; 1999 May 30; 51(2):179-85. PubMed ID: 10435811
    [Abstract] [Full Text] [Related]

  • 29. Enhancement of the cytotoxicity of SR 4233 to normal and malignant tissues by hypoxic breathing.
    Minchinton AI, Brown JM.
    Br J Cancer; 1992 Dec 30; 66(6):1053-8. PubMed ID: 1457345
    [Abstract] [Full Text] [Related]

  • 30. DNA damage measured by the comet assay in head and neck cancer patients treated with tirapazamine.
    Dorie MJ, Kovacs MS, Gabalski EC, Adam M, Le QT, Bloch DA, Pinto HA, Terris DJ, Brown JM.
    Neoplasia; 1999 Nov 30; 1(5):461-7. PubMed ID: 10933062
    [Abstract] [Full Text] [Related]

  • 31. Dual-function 2-nitroimidazoles as hypoxic cell radiosensitizers and bioreductive cytotoxins: in vivo evaluation in KHT murine sarcomas.
    Cole S, Stratford IJ, Adams GE, Fielden EM, Jenkins TC.
    Radiat Res; 1990 Oct 30; 124(1 Suppl):S38-43. PubMed ID: 2236508
    [Abstract] [Full Text] [Related]

  • 32. Hypobaric hypoxia: a method for testing bioreductive drugs in vivo.
    McAleer JJ, McKeown SR, MacManus MP, Lappin TR, Bridges JM.
    Int J Radiat Oncol Biol Phys; 1992 Oct 30; 23(3):551-5. PubMed ID: 1612955
    [Abstract] [Full Text] [Related]

  • 33. Bioreductive therapy.
    Chaplin DJ.
    Int J Radiat Oncol Biol Phys; 1992 Oct 30; 22(4):685-7. PubMed ID: 1544837
    [No Abstract] [Full Text] [Related]

  • 34. The repair of DNA damage induced in V79 mammalian cells by the nitroimidazole-aziridine, RSU-1069. Implications for radiosensitization.
    Jenner TJ, O'Neill P, Crump PW, Fielden EM, Sapora O, Santodonato L.
    Biochem Pharmacol; 1991 Oct 09; 42(9):1705-10. PubMed ID: 1930296
    [Abstract] [Full Text] [Related]

  • 35. Hypoxic fractions measured in murine tumors and normal tissues using the comet assay.
    Olive PL, Vikse CM, Durand RE.
    Int J Radiat Oncol Biol Phys; 1994 Jun 15; 29(3):487-91. PubMed ID: 8005804
    [Abstract] [Full Text] [Related]

  • 36. Bioreductive drugs as post-irradiation sensitizers: comparison of dual function agents with SR 4233 and the mitomycin C analogue EO9.
    Adams GE, Stratford IJ, Edwards HS, Bremner JC, Cole S.
    Int J Radiat Oncol Biol Phys; 1992 Jun 15; 22(4):717-20. PubMed ID: 1544844
    [Abstract] [Full Text] [Related]

  • 37. Repair of DNA and chromosome breaks in cells exposed to SR 4233 under hypoxia or to ionizing radiation.
    Wang J, Biedermann KA, Brown JM.
    Cancer Res; 1992 Aug 15; 52(16):4473-7. PubMed ID: 1643639
    [Abstract] [Full Text] [Related]

  • 38. SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours.
    Brown JM.
    Br J Cancer; 1993 Jun 15; 67(6):1163-70. PubMed ID: 8512801
    [Abstract] [Full Text] [Related]

  • 39. Influence of oxygen on radiation-induced DNA damage in testicular cells of C3H mice.
    Zheng H, Olive PL.
    Int J Radiat Biol; 1997 Mar 15; 71(3):275-82. PubMed ID: 9134017
    [Abstract] [Full Text] [Related]

  • 40. Effects of bioreductive agents, tirapazamine and mitomycin C, on quiescent cell populations in solid tumors, evaluated by micronucleus assay.
    Masunaga S, Ono K, Hori H, Shibata T, Suzuki M, Kinashi Y, Takagaki M, Akaboshi M.
    Jpn J Cancer Res; 1997 Sep 15; 88(9):907-14. PubMed ID: 9369940
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.